N | С |
zy | 20pg/mL-320pg/mL |
ҺwM֑壬oнM֑obƓp | |
; | zyѪѪ{B(yng)ҺMС8-ǰأ8-isoprostaneĺ |
ԭ | ԇвø(lin)߷ؘӛ8-ǰأ8-isoprostaneĿ8-ǰأ8-isoprostanewװڸƷһĹwcؘӛ8-ǰأ8-isoprostaneǘӛԭУƷ˱MƸwcؘӛ8-ǰأ8-isoprostaneYܷǘӛԭǘӛԭ,wcؘӛ8-ǰأ8-isoprostaneYϾ٣֮YϾͶƽγɹw-ػSyndecan-4ټøӛHγɹw-ػ8-ǰأ8-isoprostane-ø-H؏ͺӵ@ɫø˃x450nmLyȣODֵS8-ǰأ8-isoprostaneȵODֵu½õľPϵԇо`ȸخԏ؏ԺٵcѪ8-ǰأ8-isoprostaneĜpٻпɿęzܡ |
خ | ԇReȻؽMС8-ǰأ8-isoprostanecYo档 |
؏ | ׃ϵ(sh) CV%С 15%g׃ϵ(sh) CV%С 15% |
85%-115%֮g | |
ԇԂԇ | 1ø˃x450nm2Һһ^3sˮ4ϴƿԄϴC537ˮԡ偻6500ml Ͳ |
1. NԇҜƽСrȡsϴҺ(j)zy(sh)sˮ 120 ϡ2. AܷȡOһհտκҺwÿУƷO 2 ÿ댦УƷ 50lÿzyֱӼӴyѪ|Ʒ 50l3. հпػԭ 50lNϷĤ 37 60 犡4. ֹϴ壺ȥ׃ҺwϴҺעMףo 10 ˦؏ 3 κĸϴCϴ壺xϴ 3 γϴĸ5. ÿøH 50lհտ׳⣩NϷĤ 37 30 6. ֹϴ壺ȥ׃ҺwϴҺעMo 10 ˦ɣ؏ 3 κĸϴCϴ壺xϴ 3 γϴĸ7. ÿ@ɫ A 50l@ɫ B 50lʎ 37ܹ@ɫ 15 ÿӽKֹҺ 50lø˃xx(sh)ȡL450nmÿհտ{cȻyֵܶODֵ | |
ע | 1ԇеĽMҪٴʹՈ_һʹ֮]бȾ2ø˰δδʹҪ֔ӛܷŵ 2-8汣 |
} | ن}˜ԭߣ1.ԇƽrg 2 СrҜƽ2.ȡϴ첻ֵ֡ȡϴ3.Һ_zУҺچ}ܶȵͿԭߣ1.ϴ첻֡fҪϴͽ2.ֺȡԇ㡪ֻȡԇ3.؏^ĤʹüӘҪQµ^ʹµķģ4.ӘӲ_zУҺۆ}O.DֵͿԭߣ1.ÿӵԇ_УҺ_ԇ2.rg_CĜrg3.ضȲ_ԇҪƽҜزCʴ_Ĝض4.øӛʧЧͨ^øӛ͵ɫѸ@F(xin)z5.]мKֹҺfEKֹҺ6.x(sh)rgx(sh)f]x(sh)rgx(sh)܆}ӱֵԭߣ1._Ęӱ淽ʽ_ӱʹrӱMЌ2._Ęӱռ̎ȡ_Ęӱռ̎3.y|ژӱк͡ʹrӱ؏͌ |
| ԓԇЃHоʹ猢R\κ;ҹ˾ˮaĆ}ؓ؟Гκη؟Ρ |
ԃ˾I(y)ՆT@ȡf
![]() | 1.҂һ48СrȰl(f)؛S؛Ԕُ؛Ρ 2.RՈrͨ^QQԒȷʽV҂ԔV҂ُaƷ(sh)ƷN؛ַԒϢtl(f)؛ |
ע
һڮaƷN^aƷϢδܼr£δڹپW(wng)ҵĮaƷֱԒQQھԃ
ӆُELISAԇеĿ͑MyԔԃNˆT
eѣ
~̖ȪƼ˾ٷտ~̖κ~̖ǟoЧՈ~̖֔_
y | | ~̖ | _ȫQ |
Їyйɷ˾ȪȪ۷ | ȪƼ˾ | 151559315 | Їyйɷ˾ȪȪ۷ |
You Keep Us Running
,Ʒ|
͑--҂ʹ͑M@ô
͑҂ķaƷ|Ķxߣ֣\ԭtdzҕ͑ҊcܣṩƷ|aƷЫ@úǰʹ҂Ŀ͑MPҪ҂@ô
ɆTd҂Ҫȡøijɹϣ҂ÿһλTԘOI(y)eOؓ؟̹\҂Ŀ͑M⣡
ώ҂κҊκέh(hun)(ji)ܵՈ(lin)ϵ҂҂r؏dzx
͑ճZ
1. ͑--҂ʹ͑M⣬@ô “͑g”͑ ĺ͑҂ķaƷ|Ķx ֣\ԭtdzҕ͑ҊcܣṩƷ|aƷЫ@úǰʹ҂Ŀ͑MPҪ҂@ô
2. r^I(y)ՆTxʹ͑˽ⲢaƷ̖gָˡʹÈȫע헵ԱC͑ںͬǰ_x͑ڽ؛ǰͮaƷ̖׃h oͨcϣԝM͑ĺҪ̖׃֮ӆΣ TںϼsǰJc͑_JԜpٽo͑ɲҪ韩͓pʧ
3. \ݔɵ؛p˾c\ݔf(xi){Q͑ГɴˮaēpʧͬrŬF(xin)l(f)؛_͑F(xin)պҽh͑_؛Ʒ^(sh)ȷMмĬF(xin)գ Mܵر⽻؛ٴγF(xin)؛pcPĆ}ʹ^У һֱעؿ͑̎Nۺˡ؛3δ\ݔ؛prtĬJ鱾؛յ
4. һʹîaƷ|CڃȰl(f)aƷ|ԭʹò˞ؓpǵɵڽӵ͑Ԓ֪ͨrMƅf(xi){؛30ȣ\κڞʣl(f)F(xin)aƷ|}Ոrcͷ(lin)ϵڲ}aƷְb(ՈԎbֱڮaƷԭSճN)Ո]ƽ]͑xʽ˻أ\Mҹ˾֧
5. ؛ǰՈcͷͨՈۺձcCϿͷ(lin)ϵ@ۺ̖Աۙ؛@ür̎͑aƷɫʽָ҂MM㣬100%Cɫʽ˓Q؛˸õķڿ͑ۺՌTԒEMAILͮaƷʹàr͑MиۙM{
6ڰѷȪƼ˾Ʒĵҹ˾r҂ȫ˓Q؛ֱ̎ӷo͑ę
7l˓Q˻صĮaƷbpaƷPYϲRδڙbδʹûA桢ۺƷ
8ۺǹ˾ķ҂ԸṩõۺͬrõۺҲҪ͑Ո˓Q؛ǰмxfMܰ˾Ҏ(gu)kӰ푌ۺա
9ώ͑ճZɆ]Ոֱ(lin)ϵ˾ھˆT늁ԃϣώ҂ķռҊĝM҂Ąףxx
УȪƼ˾ | }ICP18019542̖ | g֧֣xW(wng)